Patterns of Red and Processed Meat Consumption and Risk for Cardiometabolic and Cancer Outcomes
FREE- Correction(s) for this article:
- correction4 February 2020
Correction: Nutritional Recommendations (NutriRECS) on Consumption of Red and Processed MeatFREE
Abstract
This article has been corrected. The original version (PDF) is appended to this article as a Supplement.
Background:
Studying dietary patterns may provide insights into the potential effects of red and processed meat on health outcomes.
Purpose:
To evaluate the effect of dietary patterns, including different amounts of red or processed meat, on all-cause mortality, cardiometabolic outcomes, and cancer incidence and mortality.
Data Sources:
Systematic search of MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL, Web of Science, and ProQuest Dissertations & Theses Global from inception to April 2019 with no restrictions on year or language.
Study Selection:
Teams of 2 reviewers independently screened search results and included prospective cohort studies with 1000 or more participants that reported on the association between dietary patterns and health outcomes.
Data Extraction:
Two reviewers independently extracted data, assessed risk of bias, and evaluated the certainty of evidence using GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria.
Data Synthesis:
Eligible studies that followed patients for 2 to 34 years revealed low- to very-low-certainty evidence that dietary patterns lower in red and processed meat intake result in very small or possibly small decreases in all-cause mortality, cancer mortality and incidence, cardiovascular mortality, nonfatal coronary heart disease, fatal and nonfatal myocardial infarction, and type 2 diabetes. For all-cause, cancer, and cardiovascular mortality and incidence of some types of cancer, the total sample included more than 400 000 patients; for other outcomes, total samples included 4000 to more than 300 000 patients.
Limitation:
Observational studies are prone to residual confounding, and these studies provide low- or very-low-certainty evidence according to the GRADE criteria.
Conclusion:
Low- or very-low-certainty evidence suggests that dietary patterns with less red and processed meat intake may result in very small reductions in adverse cardiometabolic and cancer outcomes.
Primary Funding Source:
None. (PROSPERO: CRD42017074074)
Observational studies have reported higher incidence of all-cause mortality, cardiometabolic diseases, and cancer outcomes in people who consume greater quantities of red meat (1–6). Consequently, most guidelines from national and international agencies recommend limiting intake of red and processed meat (7–9). However, additional scrutiny of the evidence to determine the extent to which current recommendations are justified is warranted, particularly given the possible methodological limitations of systematic reviews to date (for example, the lack of consideration of the overall certainty of evidence) and other confounding factors (10, 11).
Foods and nutrients are not consumed in isolation, and their effects may differ depending on the totality of one's diet and how dietary habits change over time. Moreover, interventions focusing on modification of intake of particular foods or nutrients require compensatory changes in other dietary components. Nevertheless, most nutritional epidemiologic research since the 1970s has focused on the effects of individual foods or nutrients (12). Given the potential for interaction, an increasingly common alternative to focusing on individual foods or nutrients is to examine the effects of dietary patterns on health outcomes (13). Two approaches are commonly used to define dietary patterns: data-driven methods, including factor analysis or principal-components analysis, or a priori approaches that use diet indices or scores based on dietary recommendations or characteristics.
This review was done to inform recommendations on red and processed meat intake from the NutriRECS (Nutritional Recommendations) consortium (14). We conducted 4 additional systematic reviews addressing evidence from randomized trials on the effect of red meat consumption on health outcomes (15), observational evidence on the association between red and processed meat consumption and cardiometabolic outcomes (16), observational evidence on the association between red and processed meat consumption and cancer outcomes (17), and qualitative and quantitative evidence on public values and preferences regarding meat consumption (18). We used the results of these to develop guideline recommendations on red and processed meat consumption (19). In this article, we report the results of a systematic review addressing the association between dietary patterns that are lower versus higher in red and processed meat intake and the risk for cardiometabolic and cancer outcomes.
Methods
This article complies with the recommendations of PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) (20). We registered the protocol in PROSPERO (CRD42017074074) on 10 August 2017.
Data Sources and Searches
With assistance from an experienced librarian, we developed a comprehensive search strategy for 5 databases: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, Web of Science, and CINAHL. We searched each database without restrictions on year or language of publication from inception to 8 July 2018, with an updated search of MEDLINE through to April 2019 (Supplement Table 1). In addition, we searched the following gray literature sources: ProQuest Dissertations & Theses Global (1989 to 2018), trial registries (ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform Search Portal), bibliographies of included articles, and relevant literature reviews. This search strategy informed all supporting NutriRECS reviews on red and processed meat (15–17) except the one addressing public values and preferences (18).
Study Selection
We included cohort studies with 1000 or more participants that reported an association between dietary patterns and 1 or more of our outcomes of interest in adults with or without cardiometabolic conditions but without cancer or any infectious or chronic noncardiometabolic conditions. We excluded studies that did not report the quantity of consumption of red and processed meat across categories of dietary habits. Red meat was defined as mammalian meat, and processed meat was defined as white or red meat preserved by smoking, curing, salting, or adding preservatives (21). We assumed serving sizes of 120 g for unprocessed red meat, 50 g for processed meat, and 100 g for mixed unprocessed red and processed meat. These were selected to be comparable to serving sizes used in other systematic reviews and to reflect those used by the U.S. Department of Agriculture and the U.K. Food Standards Agency (4–7). We also included studies comparing vegetarians with nonvegetarians. When more than 1 eligible article reported on the same exposure and cohort and addressed the same outcome, we included only results from the article with the longest follow-up. If the duration of follow-up was the same across articles, we included the article with the largest number of participants, resulting in each unique cohort study as the unit of analysis.
The panel for the NutriRECS guideline on red and processed meat, which comprised members of the public and clinicians, including dietitians, epidemiologists, and methodologists, selected the outcomes of interest for this systematic review (14, 22). These included major cardiometabolic morbidity and mortality; incidence of or mortality associated with gastrointestinal, breast, gynecologic, and prostate cancer; quality of life; and satisfaction with diet.
Reviewers conducted pilot screening exercises and received detailed instructions for each item before screening. Pairs of reviewers independently screened titles and abstracts in duplicate and reviewed the full-text articles of those found to be potentially eligible. Reviewers resolved disagreements by discussion or, if necessary, by third-party adjudication.
Data Extraction and Risk-of-Bias Assessment
Reviewers conducted calibration exercises and worked in duplicate to independently extract data. We used a standardized, piloted data abstraction form. The reviewers resolved disagreements by discussion or, if necessary, by third-party adjudication involving a senior investigator. We extracted the following information from each study: setting, number of participants at baseline and follow-up, age, sex, method of diet assessment, dietary pattern data (intake of red and processed meat), type of cancer or cardiometabolic disease, years of follow-up, and effect estimates and corresponding 95% CIs.
Reviewers, independently and in duplicate, assessed risk of bias of each eligible study by using a modified version of the CLARITY (Clinical Advances Through Research and Information Translation) instrument (23, 24), with omission of 1 item related to co-interventions that was not relevant to our review (Supplement Table 3). We rated each item as having definitely low, probably low, probably high, or definitely high risk of bias. We adapted item 2 (assessment of exposure) to address the validity of dietary measures. For example, if a study measured diet at least once every 5 years using a food-frequency questionnaire validated against a weighted food record for red and processed meat, it was deemed to have definitely low risk of bias for this item. We also adapted item 4 (adjustment for prognostic factors) on the basis of established prognostic factors for each outcome of interest. Consultation with research methodologists and nutrition researchers confirmed the appropriateness of the instrument and informed criteria to evaluate each item. We considered each item to be equally important. Risk of bias was evaluated at the outcome level and not the study level. We considered studies that were rated to have high risk of bias on 2 or more of the 7 domains to have high overall risk of bias. Although this threshold is arbitrary, it represents a compromise between excessive stringency and leniency and facilitates subgroup analysis by providing an approximately even division between studies at higher versus lower risk of bias.
Data Synthesis and Analysis
The lowest category (for example, tertiles or quartiles) of adherence to dietary patterns high in red and processed meat was compared with the highest category as a proxy to determine the dietary patterns lower versus higher in red and processed meat consumption. When a single study investigated multiple dietary patterns, our analysis focused on the one with the greatest difference in red or processed meat intake between the lowest and highest categories. In studies that investigated multiple dietary patterns, we used factor analysis or principal-component analysis to analyze the patterns with the highest factor loadings for red meat, processed meat, or both. Using the Hartung–Knapp–Sidik–Jonkman model (25, 26) and a DerSimonian–Laird random-effects model as a sensitivity analysis (27), we conducted meta-analyses comparing the lowest and highest categories of intake. For studies in which the outcomes of interest were reported stratified by participant characteristics (for example, sex) with no overlap in participants or events across strata, we meta-analyzed across subgroups. We calculated the risk difference by multiplying the pooled effect estimate from our meta-analyses by the baseline risk for cancer incidence or mortality, which was based on GLOBOCAN cumulative lifetime risks (28, 29). For cardiometabolic disease, data from the Emerging Risk Factors Collaboration (30) provided the baseline risk to calculate risk differences over 10.8 years.
We conducted subgroup analyses for each outcome based on our assessment of overall risk of bias for each study. When we found a statistically significant subgroup effect based on risk of bias, we present results for studies with low risk of bias. We also conducted a subgroup analysis based on the methods for defining dietary patterns.
Certainty of Evidence
One investigator assessed the certainty of evidence as high, moderate, low, or very low for each outcome using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria (31), with all assessments confirmed by senior investigators. According to the GRADE approach, observational studies may provide moderate- or high-certainty evidence if they show a large magnitude of effect or a dose-response gradient and when suspected biases work against the observed direction of effect. Observational studies without these characteristics provide low-certainty evidence, and those that are also limited by risk of bias, inconsistency, indirectness, imprecision, or publication bias provide very-low-certainty evidence (32–37).
Role of the Funding Source
This study received no funding.
Results
Of the 13 154 unique citations initially identified by our search, 11 653 were deemed ineligible after title and abstract screening (Figure). Among the 1501 full-text articles evaluated, 105 were potentially eligible, yielding 70 unique cohorts with 6 035 051 participants. Most of the cohorts (83%) were also included in the accompanying systematic reviews (16, 17) to support the guideline recommendation.

The articles were published between 1994 and 2018 and included 1804 to 492 382 participants followed for 2.0 to 34.3 years. The mean age of participants at enrollment ranged from 33 to 71 years, with most studies including a majority of participants aged 50 to 60 years, and the proportion of women ranged from 0% to 100%, with most studies including a similar number of men and women. Six studies recruited participants with preexisting cardiometabolic conditions, the most common being hypertension. Supplement Table 2 shows additional study characteristics.
Investigators used a wide variety of methods to define dietary patterns (Supplement Table 2). In 63 cohort studies (60%), a posteriori dietary patterns derived from factor analyses, principal-component analyses, cluster analyses, or reduced-rank regressions were used. Among studies using factor analysis or principal-component analysis, dietary patterns were derived by the covariance matrix of individual foods to reduce the dimensionality from a high number of foods to a few patterns of food consumption that explained the maximum variation in dietary habits (13). The resultant patterns were aggregates of foods that were highly correlated with one another. Patterns derived by principal-component analysis were linear combinations of the observed variables, whereas factors derived by factor analysis were latent constructs. The emerging patterns were often adjusted using an “orthogonal rotation” so that the final patterns were uncorrelated. For each pattern, summary factor scores were obtained that defined each participant's degree of adherence. Among studies in which reduced-rank regression was used, linear combinations of foods that maximally explained a set of intermediate or surrogate measures of the outcome of interest (such as biomarker levels) were derived and pattern scores were obtained that, similar to factor scores, represented each participant's degree of adherence to the pattern (38). In studies that used cluster analysis, the k-means method was used to identify aggregates of participants with similar dietary habits (13).
In 15 studies, dietary patterns were defined a priori using indices or scoring systems. Of the eligible studies, 19 investigated vegetarian versus nonvegetarian participants for at least 1 of our outcomes of interest. Our subgroup analyses found no differences among the various methods used to determine dietary patterns for any outcome (Supplement Table 4).
Red and processed meat intake varied widely across categories. Thirty studies recorded a quantitative estimate of red or processed meat consumption (for example, grams per day or servings per week), and others solely reported the factor loadings or compared vegetarians versus nonvegetarians without information on meat consumption. Among the 27 studies reporting on red meat intake (unprocessed, unspecified, or mixed), the difference between extreme adherence categories was less than 2 servings per week in 6 studies, 2 to 5 servings per week in 17 studies, and more than 5 servings per week in 4 studies. In the 19 studies reporting on intake of processed meat, the difference between extreme adherence categories was less than 2 servings per week in 4 studies, 2 to 5 servings per week in 13 studies, and more than 5 servings per week in 2 studies.
Risk-of-Bias Assessment
Supplement Table 3 presents risk of bias for each study and outcome. The percentage of studies with high overall risk of bias varied across outcomes (10 of 24 [42%] for all-cause mortality, 13 of 25 [52%] for cardiovascular mortality, 3 of 5 [60%] for fatal and nonfatal stroke, 0 of 2 [0%] for myocardial infarction, 7 of 12 [58%] for cardiovascular disease, 2 of 3 [67%] for overall cancer incidence, 8 of 18 [44%] for overall cancer mortality, and 9 of 14 [64%] for type 2 diabetes). The most common methodological limitations were lack of repeated measurement of intake in the dietary patterns, use of a measure that was not validated for red and/or processed meat, and inadequate adjustment for potential confounders. We did not find significant differences in any outcome for the studies judged to have high versus low risk of bias (Supplement Table 5).
All-Cause Mortality
We found a small decrease in risk for all-cause mortality associated with dietary patterns lower in red or processed meat intake. Evidence was rated to have very low certainty due to inconsistency (Table 1).
![]() |
Cardiovascular Outcomes
Dietary patterns lower in red and processed meat intake were associated with decreased risk for cardiovascular mortality, based on very-low-certainty evidence due to inconsistency (Table 1). Low-certainty evidence showed a small reduction in risk for nonfatal stroke for dietary patterns low in red and processed meat intake but no statistically significant associations for risk for overall stroke and fatal stroke.
We did not observe a statistically significant association between dietary patterns and risk for fatal and nonfatal myocardial infarction, fatal and nonfatal cardiovascular disease, and nonfatal cardiovascular disease (Table 1).
Type 2 Diabetes
We found a very small reduction in risk for type 2 diabetes associated with dietary patterns lower in red or processed meat consumption (Table 1). The overall certainty of this evidence was very low due to inconsistency.
Cancer Outcomes
Dietary patterns lower in red and processed meat intake were associated with a small to very small reduction in risk for overall cancer incidence and mortality (Table 2). However, this evidence was considered to have very low certainty for overall cancer incidence (due to imprecision) and overall cancer mortality (due to inconsistency). No statistically significant risk was found for dietary patterns lower in red and processed meat intake for incidence of breast, colorectal, endometrial, liver, ovarian, pancreatic, prostate, stomach, and uterine cancer. Similarly, we found no differences among dietary patterns in risk estimates for mortality associated with breast, colorectal, esophageal, liver, ovarian, prostate, and stomach cancer.
![]() |
We found low-certainty evidence that dietary patterns lower in red or processed meat consumption were associated with a very small reduction in risk for incidence of extrahepatic and gallbladder cancer. Low-certainty evidence also suggested that risk for death due to pancreatic cancer was lower for the dietary patterns with low intake of red or processed meat.
Discussion
In this systematic review and meta-analysis of 70 unique cohorts with 6 035 051 participants, we found low- to very-low-certainty evidence that dietary patterns lower in red or processed meat intake result in a small to very small reduction in risk for all-cause mortality, cardiovascular mortality, fatal coronary heart disease, fatal myocardial infarction, overall cancer mortality, overall cancer incidence, and type 2 diabetes (Tables 1 and 2).
Strengths of our review include a priori–defined methods (22); a comprehensive search of 6 primary databases using a strategy developed by an expert librarian; duplicate screening of studies for eligibility, data extraction, and assessment of risk of bias; and inclusion of a large number of studies and participants. Further, we used the GRADE approach to assess the certainty of evidence and to present absolute estimates of effect for all 30 outcomes.
One of the primary limitations of our work is the heterogeneity of dietary patterns across studies. Although all patterns discriminated between participants with low and high intake of red and processed meat, other food and nutrient characteristics of dietary patterns and the quantity of red and processed meat consumed varied widely across studies. Moreover, the quantity of red and processed meat consumed differed across dietary patterns and studies. For example, one study compared 1.4 versus 3.5 servings of processed meat per week (39), whereas another compared 0.7 versus 4.9 servings per week (40). Such inconsistencies may have increased heterogeneity of meta-analyses and potentially reduced the magnitude of observed associations. Also, analyses of extreme categories of adherence may artificially inflate effect estimates and may not be indicative of effects observed at typical levels of adherence. Second, we were unable to analyze the data separately for red and processed meat because authors typically combined them or did not distinguish between them in primary studies. Third, all eligible studies used observational designs and were thus prone to confounding. Although we minimized confounding by using the most adjusted analyses from each study in our meta-analyses, residual confounding remains a plausible explanation for all associations. Finally, eligible studies used recall-based methods for dietary measurement that are prone to measurement error, which can result in either an underestimate or an overestimate of observed associations (41, 42).
Although previous reviews have reported a positive association between red and processed meat intake and all-cause mortality, cardiovascular disease, stroke, myocardial infarction, and type 2 diabetes (4, 6, 10, 11), our systematic review is, to our knowledge, the first to address dietary patterns with respect to red and processed meat consumption and to include an assessment of the certainty of evidence. The 2010 Dietary Guidelines Advisory Committee of the U.S. Department of Agriculture conducted a project that summarized the evidence on dietary patterns and their effect on health, including obesity, cardiovascular disease, and type 2 diabetes (43). In general, although some dietary patterns, such as low-carbohydrate diets, were not considered, no single dietary pattern was associated with more favorable health outcomes. However, the Mediterranean-style diet, the DASH (Dietary Approaches to Stop Hypertension) diet, and Dietary Guidelines–related patterns were consistently associated with positive health outcomes (43).
Our work complements other systematic reviews performed to address NutriRECS recommendations on red and processed meat consumption. Although we found a small to very small decrease in risk for several adverse health outcomes, the effect sizes observed in our dose-response meta-analyses that directly addressed red and processed meat were, in general, only slightly smaller (16, 17). For example, studies directly addressing meat consumption suggested that a reduction of 3 servings per week resulted in 8 (red meat) and 9 (processed meat) fewer deaths per 1000 persons (16), whereas we found 15 fewer deaths per 1000 persons among those adhering to dietary patterns lower in red and processed meat consumption. Similarly, studies directly addressing meat consumption found that a reduction of 3 servings per week may decrease lifetime risk for cancer death by 7 (red meat) and 8 (processed meat) deaths per 1000 persons (17) versus 12 deaths per 1000 persons observed in this review. If red and processed meat were causally driving the association between diet and adverse health outcomes, we would anticipate finding stronger associations in our systematic reviews specific to red and processed meat intake (14, 22), but we did not. Our findings indicate the possibility that dietary components associated with red and processed meat intake may confound its association with health outcomes. However, inferences about causality should be interpreted with caution given the low- to very-low-certainty evidence.
Because of concerns about adverse health outcomes, recent dietary guidelines recommend limiting red and processed meat intake in cultures with traditionally high red meat consumption (1, 7–9). The results of our systematic review raise concerns about these recommendations. First, we identified only low-certainty (and often very-low-certainty) evidence linking dietary patterns lower in red and processed meat intake with small reductions in adverse cardiometabolic and cancer outcomes, making causal inferences tenuous. Second, our results suggest that dietary patterns lower in red or processed meat intake are associated with a small or, in most cases, very small reduction in risk for all-cause mortality, 3 cardiometabolic outcomes, and 5 cancer outcomes. Third, our findings of stronger associations in studies of dietary patterns high in red and processed meat intake compared with studies directly addressing red and processed meat consumption suggest the possibility of confounding by other dietary characteristics correlated with red and processed meat consumption.
In conclusion, adherence to dietary patterns lower in red or processed meat intake may result in decreased risk for all-cause mortality, cardiometabolic disease and mortality, and cancer morbidity and mortality. Nevertheless, the magnitude of these effects for all outcomes is small to very small, and the certainty of evidence is low to very low. Our results therefore raise questions about the plausibility of red and processed meat being causally related to adverse health outcomes.
References
- 1.
Bouvard V ,Loomis D ,Guyton KZ ,et al .International Agency for Research on Cancer Monograph Working Group . Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015;16:1599-600. [PMID:26514947 ] doi:10.1016/S1470-2045(15)00444-1 CrossrefMedlineGoogle Scholar - 2.
Sinha R ,Cross AJ ,Graubard BI ,et al . Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med. 2009;169:562-71. [PMID:19307518 ] doi:10.1001/archinternmed.2009.6 CrossrefMedlineGoogle Scholar - 3.
Song Y ,Manson JE ,Buring JE ,et al . A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the Women's Health Study. Diabetes Care. 2004;27:2108-15. [PMID:15333470 ] CrossrefMedlineGoogle Scholar - 4.
Schwingshackl L ,Schwedhelm C ,Hoffmann G ,et al . Food groups and risk of all-cause mortality: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2017;105:1462-73. [PMID:28446499 ] doi:10.3945/ajcn.117.153148 CrossrefMedlineGoogle Scholar - 5.
Abete I ,Romaguera D ,Vieira AR ,et al . Association between total, processed, red and white meat consumption and all-cause, CVD and IHD mortality: a meta-analysis of cohort studies. Br J Nutr. 2014;112:762-75. [PMID:24932617 ] doi:10.1017/S000711451400124X CrossrefMedlineGoogle Scholar - 6.
Chen GC ,Lv DB ,Pang Z ,et al . Red and processed meat consumption and risk of stroke: a meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2013;67:91-5. [PMID:23169473 ] doi:10.1038/ejcn.2012.180 CrossrefMedlineGoogle Scholar - 7.
U.S. Department of Health and Human Services; U.S. Department of Agriculture . 2015–2020 Dietary Guidelines for Americans. 8th ed. Washington, DC U.S. Department of Agriculture 2015. Google Scholar - 8.
Public Health England . The Eatwell Guide. London Public Health England 2016. Google Scholar - 9. World Cancer Research Fund; American Institute for Cancer Research. Meat, fish and dairy products and the risk of cancer. 2018. Accessed at www.wcrf.org/dietandcancer/exposures/meat-fish-dairy on 1 May 2019. Google Scholar
- 10.
Wang X ,Lin X ,Ouyang YY ,et al . Red and processed meat consumption and mortality: dose-response meta-analysis of prospective cohort studies. Public Health Nutr. 2016;19:893-905. [PMID:26143683 ] doi:10.1017/S1368980015002062 CrossrefMedlineGoogle Scholar - 11.
Micha R ,Wallace SK , andMozaffarian D . Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation. 2010;121:2271-83. [PMID:20479151 ] doi:10.1161/CIRCULATIONAHA.109.924977 CrossrefMedlineGoogle Scholar - 12.
Kant AK . Dietary patterns and health outcomes. J Am Diet Assoc. 2004;104:615-35. [PMID:15054348 ] CrossrefMedlineGoogle Scholar - 13.
Hu FB . Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002;13:3-9. [PMID:11790957 ] CrossrefMedlineGoogle Scholar - 14.
Johnston BC ,Alonso-Coello P ,Bala MM ,et al . Methods for trustworthy nutritional recommendations NutriRECS (Nutritional Recommendations and accessible Evidence summaries Composed of Systematic reviews): a protocol. BMC Med Res Methodol. 2018;18:162. [PMID:30518328 ] doi:10.1186/s12874-018-0621-8 CrossrefMedlineGoogle Scholar - 15.
Zeraatkar D ,Johnston BC ,Bartoszko J ,et al . Effect of lower versus higher red meat intake on cardiometabolic and cancer outcomes. A systematic review of randomized trials. Ann Intern Med. 2019;171:721-31. doi:10.7326/M19-0622 LinkGoogle Scholar - 16.
Zeraatkar D ,Han MA ,Guyatt GH ,et al . Red and processed meat consumption and risk for all-cause mortality and cardiometabolic outcomes. A systematic review and meta-analysis of cohort studies. Ann Intern Med. 2019;171:703-10. doi:10.7326/M19-0655 LinkGoogle Scholar - 17.
Han MA ,Zeraatkar D ,Guyatt GH ,et al . Reduction of red and processed meat intake and cancer mortality and incidence. A systematic review and meta-analysis of cohort studies. Ann Intern Med. 2019;171:711-20. doi:10.7326/M19-0699 LinkGoogle Scholar - 18.
Valli C ,Rabassa M ,Johnston BC ,et al . Health-related values and preferences regarding meat consumption. A mixed-methods systematic review. Ann Intern Med. 2019;171:742-55. doi:10.7326/M19-1326 LinkGoogle Scholar - 19.
Johnston BC ,Zeraatkar D ,Han MA ,et al . Unprocessed red meat and processed meat consumption: dietary guideline recommendations from the Nutritional Recommendations (NutriRECS) Consortium. Ann Intern Med. 2019;171:756-64. doi:10.7326/M19-1621 LinkGoogle Scholar - 20.
Moher D ,Liberati A ,Tetzlaff J ,et al .PRISMA Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-9, W64 LinkGoogle Scholar - 21.
Wiseman M . The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. 2008;67:253-6. [PMID:18452640 ] doi:10.1017/S002966510800712X CrossrefMedlineGoogle Scholar - 22. Zeraatkar D, Bala M, Webber-Adams T, et al. Red meat and health outcomes: a systematic review. PROSPERO. 2017. Accessed at www.crd.york.ac.uk/prospero/display_record.php?RecordID=74074 on 22 August 2019. Google Scholar
- 23.
Higgins JP ,Altman DG ,Gøtzsche PC ,et al .Cochrane Bias Methods Group . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. [PMID:22008217 ] doi:10.1136/bmj.d5928 CrossrefMedlineGoogle Scholar - 24. Evidence Partners. Tool to Assess Risk of Bias in Cohort Studies. Accessed at http://help.magicapp.org/knowledgebase/articles/327941-tool-to-assess-risk-of-bias-in-cohort-studies on 4 September 2019. Google Scholar
- 25.
Hartung J . An alternative method for meta-analysis. Biom J. 1999;41:901-16. CrossrefGoogle Scholar - 26.
Hartung J andKnapp G . A refined method for the meta-analysis of controlled clinical trials with binary outcome. Stat Med. 2001;20:3875-89. [PMID:11782040 ] CrossrefMedlineGoogle Scholar - 27.
DerSimonian R andLaird N . Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88. [PMID:3802833 ] CrossrefMedlineGoogle Scholar - 28.
Ferlay J ,Soerjomataram I ,Dikshit R ,et al . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-86. [PMID:25220842 ] doi:10.1002/ijc.29210 CrossrefMedlineGoogle Scholar - 29. Ferlay J, Soerjomataram I, Ervik M, et al, eds. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. IARC CancerBase No. 11. Accessed at https://publications.iarc.fr/Databases/Iarc-Cancerbases/GLOBOCAN-2012-Estimated-Cancer-Incidence-Mortality-And-Prevalence-Worldwide-In-2012-V1.0-2012 on 21 August 2019. Google Scholar
- 30.
Sarwar N ,Gao P ,Seshasai SR ,et al .Emerging Risk Factors Collaboration . Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215-22. [PMID:20609967 ] doi:10.1016/S0140-6736(10)60484-9 CrossrefMedlineGoogle Scholar - 31.
Guyatt GH ,Oxman AD ,Vist GE ,et al .GRADE Working Group . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-6. [PMID:18436948 ] doi:10.1136/bmj.39489.470347.AD CrossrefMedlineGoogle Scholar - 32.
Guyatt GH ,Oxman AD ,Vist G ,et al . GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias). . J Clin Epidemiol. 2011;64:407-15. [PMID:21247734 ] doi:10.1016/j.jclinepi.2010.07.017 CrossrefMedlineGoogle Scholar - 33.
Guyatt GH ,Oxman AD ,Kunz R ,et al . GRADE guidelines 6. Rating the quality of evidence—imprecision. J Clin Epidemiol. 2011;64:1283-93. [PMID:21839614 ] doi:10.1016/j.jclinepi.2011.01.012 CrossrefMedlineGoogle Scholar - 34.
Guyatt GH ,Oxman AD ,Kunz R ,et al .GRADE Working Group . GRADE guidelines: 7. Rating the quality of evidence—inconsistency. J Clin Epidemiol. 2011;64:1294-302. [PMID:21803546 ] doi:10.1016/j.jclinepi.2011.03.017 CrossrefMedlineGoogle Scholar - 35.
Guyatt GH ,Oxman AD ,Kunz R ,et al .GRADE Working Group . GRADE guidelines: 8.Rating the quality of evidence—indirectness. J Clin Epidemiol. 2011;64:1303-10. [PMID:21802903 ] doi:10.1016/j.jclinepi.2011.04.014 CrossrefMedlineGoogle Scholar - 36.
Guyatt GH ,Oxman AD ,Montori V ,et al . GRADE guidelines: 5.Rating the quality of evidence—publication bias. . J Clin Epidemiol. 2011;64:1277-82. [PMID:21802904 ] doi:10.1016/j.jclinepi.2011.01.011 CrossrefMedlineGoogle Scholar - 37.
Guyatt GH ,Oxman AD ,Sultan S ,et al .GRADE Working Group . GRADE guidelines: 9.Rating up the quality of evidence. . J Clin Epidemiol. 2011;64:1311-6. [PMID:21802902 ] doi:10.1016/j.jclinepi.2011.06.004 CrossrefMedlineGoogle Scholar - 38.
Hoffmann K ,Schulze MB ,Schienkiewitz A ,et al . Application of a new statistical method to derive dietary patterns in nutritional epidemiology. Am J Epidemiol. 2004;159:935-44. [PMID:15128605 ] CrossrefMedlineGoogle Scholar - 39.
de Koning L ,Fung TT ,Liao X ,et al . Low-carbohydrate diet scores and risk of type 2 diabetes in men. Am J Clin Nutr. 2011;93:844-50. [PMID:21310828 ] doi:10.3945/ajcn.110.004333 CrossrefMedlineGoogle Scholar - 40.
van Dam RM ,Rimm EB ,Willett WC ,et al . Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. . Ann Intern Med. 2002;136:201-9 LinkGoogle Scholar - 41.
Archer E ,Marlow ML , andLavie CJ . Controversy and debate: Memory-Based Methods Paper 1: the fatal flaws of food frequency questionnaires and other memory-based dietary assessment methods. J Clin Epidemiol. 2018;104:113-24. [PMID:30121379 ] doi:10.1016/j.jclinepi.2018.08.003 CrossrefMedlineGoogle Scholar - 42.
Brakenhoff TB ,van Smeden M ,Visseren FLJ ,et al . Random measurement error: why worry? An example of cardiovascular risk factors. . PLoS One. 2018;13:e0192298. [PMID:29425217 ] doi:10.1371/journal.pone.0192298 CrossrefMedlineGoogle Scholar - 43. U.S. Department of Agriculture. Dietary Patterns and Risk of Cardiovascular Disease. Alexandria, VA: U.S. Department of Agriculture; 2014. Accessed at https://nesr.usda.gov/dietary-patterns-and-risk-cardiovascular-disease on 4 September 2019. Google Scholar
Author, Article and Disclosure Information
Acknowledgment: The authors thank Thomasin Adams-Webber (Hospital for Sick Children) for her help in designing the search strategy.
Disclosures: Dr. El Dib received a São Paulo Research Foundation scholarship (2018/11205-6) and support from the National Council for Scientific and Technological Development (CNPq 310953/2015-4). Dr. Sievenpiper reports grants from the Canadian Institutes of Health Research, the Calorie Control Council, the Canada Foundation for Innovation, and the Ministry of Research and Innovation's Ontario Research Fund during the conduct of the study; grants from the Canadian Institutes of Health Research, the Nutrition Trialists Fund at the University of Toronto, the International Nut and Dried Fruit Council Foundation, the Tate & Lyle Nutritional Research Fund at the University of Toronto, the American Society for Nutrition, the Glycemic Control and Cardiovascular Disease in Type 2 Diabetes Fund at the University of Toronto, and the National Dried Fruit Trade Association outside the submitted work; a PSI Graham Farquharson Knowledge Translation Fellowship, a Diabetes Canada Clinician Scientist award, a CIHR INMD/CNS New Investigator Partnership Prize, and a Banting & Best Diabetes Centre Sun Life Financial New Investigator Award outside the submitted work; personal fees from Perkins Coie, Tate & Lyle, Dairy Farmers of Canada, PepsiCo, FoodMinds, European Fruit Juice Association, International Sweeteners Association, Nestlé, the Canadian Society of Endocrinology and Metabolism, the GI Foundation, Pulse Canada, Mott's, the Canadian Nutrition Society, Abbott, BioFortis, the European Food Safety Authority, and the Physicians Committee for Responsible Medicine outside the submitted work; nonfinancial support from Tate & Lyle, PepsiCo, FoodMinds, the European Fruit Juice Association, the International Sweeteners Association, Nestlé, Mott's, the Canadian Nutrition Society, Abbott, BioFortis, the European Food Safety Authority, the Physicians Committee for Responsible Medicine, Kellogg Canada, the American Peanut Council, Barilla, Unilever, Unico Primo, Loblaw Companies, WhiteWave Foods, Quaker Oats, the California Walnut Commission, and the Almond Board of California outside the submitted work; membership in the International Carbohydrate Quality Consortium and the clinical practice guidelines expert committees of Diabetes Canada, the European Association for the Study of Diabetes (EASD), the Canadian Cardiovascular Society, and Obesity Canada; appointments as an executive board member of the Diabetes and Nutrition Study Group of the EASD, director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation, and an unpaid scientific advisor for the Food, Nutrition, and Safety Program and the Technical Committee on Carbohydrates of the International Life Science Institute North America; and a spousal relationship with an employee of Sobeys. Dr. de Souza reports personal fees and nonfinancial support from the World Health Organization; personal fees from the Canadian Institutes of Health Research/Health Canada and McMaster Children's Hospital; grants from the Canadian Foundation for Dietetic Research, Canadian Institutes for Health Research, Hamilton Health Sciences Corporation, and Hamilton Health Sciences Corporation/Population Health Research Institute outside of the submitted work. He also reports other support from the College of Family Physicians of Canada, Royal College (speaking at a recent conference), and he has served on the Board of Directors of the Helderleigh Foundation. Dr. Johnston received a grant from Texas A&M AgriLife Research to fund investigator-driven research related to saturated and polyunsaturated fats within the 36-month reporting period required by the International Committee of Medical Journal Editors, as well as funding received from the International Life Science Institute (North America) that ended before the 36-month reporting period. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-1583.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Catharine B. Stack, PhD, MS, Deputy Editor, Statistics, reports that she has stock holdings in Pfizer, Johnson & Johnson, and Colgate-Palmolive. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.
>Reproducible Research Statement: Study protocol: Available at www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=74074. Statistical code: Available from Ms. Zeraatkar (e-mail, [email protected]). Data set: Available from Dr. Vernooij (e-mail, [email protected]) or Dr. Johnston (e-mail, [email protected]).
Corresponding Author: Bradley C. Johnston, PhD, Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Room 404, 5790 University Avenue, Halifax, Nova Scotia B3J 0E4, Canada; e-mail, [email protected].
Current Author Addresses: Dr. Vernooij: Department of Research, Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, Utrecht 3511DT, the Netherlands.
Ms. Zeraatkar and Drs. Chang and Hanna: Department of Health Research Methods, Evidence, and Impact, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4K1, Canada.
Dr. Han: Department of Preventive Medicine, School of Medicine, Chosun University, 309 Philmum-daero, Dong-gu, Gwangju 61452, Republic of Korea.
Dr. El Dib: Institute of Science and Technology, Universidade Estadual Paulista, Avenida Engenheiro Francisco José Longo, 777, Jardim São Dimas, São José dos Campos, São Paulo 12245-000, Brazil.
Mr. Zworth, Mr. Milio, Mr. Lee, and Dr. Guyatt: McMaster University, Health Sciences Center, 1280 Main Street West, Hamilton, Ontario L8S 4L8, Canada.
Dr. Sit: Department of Medicine, University of British Columbia, 107-1165 West 13th Avenue, Vancouver, British Columbia V6H 1N4, Canada.
Ms. Gomaa: Department of Biostatistics, High Institute of Public Health, Alexandria University, 165 El-Horreya Avenue – El-Ibrahimia, Alexandria, Egypt.
Ms. Valli and Dr. Alonso-Coello: Iberoamerican Cochrane Centre, Carrer de Sant Antoni Maria Claret, 167, Barcelona 08025, Spain.
Dr. Swierz: Department of Hygiene and Dietetics, Jagiellonian University Medical College, Kopernika 7, 31-034, Krakow 30019, Poland.
Dr. Brauer: Department of Family Relations and Applied Nutrition, University of Guelph, 50 Stone Road East, Guelph, Ontario N1G 2W1, Canada.
Dr. Sievenpiper: St. Michael's Hospital, #6138-61 Queen Street East, Toronto, Ontario M5C 2T2, Canada.
Dr. de Souza: McMaster University, 1280 Main Street West, MDCL, Room 3210, Hamilton, Ontario L8S 4K1, Canada.
Dr. Bala: Chair of Epidemiology and Preventive Medicine, Department of Hygiene and Dietetics, Jagiellonian University Medical College, Kopernika 7, Krakow 30019, Poland.
Dr. Johnston: Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Room 404, 5790 University Avenue, Halifax, Nova Scotia B3J 0E4, Canada.
Author Contributions: Conception and design: R.W.M. Vernooij, D. Zeraatkar, Y. Chang, S.E. Hanna, P.M. Brauer, J. Sievenpiper, R. de Souza, G.H. Guyatt, B.C. Johnston.
Analysis and interpretation of the data: R.W.M. Vernooij, D. Zeraatkar, S.E. Hanna, G.H. Guyatt, B.C. Johnston.
Drafting of the article: R.W.M. Vernooij, D. Zeraatkar, B.C. Johnston.
Critical revision of the article for important intellectual content: R.W.M. Vernooij, D. Zeraatkar, M.A. Han, C. Valli, S.E. Hanna, P.M. Brauer, J. Sievenpiper, R. de Souza, P. Alonso-Coello, M.M. Bala, G.H. Guyatt, B.C. Johnston.
Final approval of the article: R.W.M. Vernooij, D. Zeraatkar, M.A. Han, R. El Dib, M. Zworth, K. Milio, D. Sit, Y. Lee, H. Gomaa, C. Valli, M.J. Swierz, Y. Chang, S.E. Hanna, P.M. Brauer, J. Sievenpiper, R. de Souza, P. Alonso-Coello, M.M. Bala, G.H. Guyatt, B.C. Johnston.
Statistical expertise: R.W.M. Vernooij, D. Zeraatkar, S.E. Hanna, G.H. Guyatt, B.C. Johnston.
Administrative, technical, or logistic support: R.W.M. Vernooij, D. Zeraatkar, R. El Dib, M. Zworth, K. Milio, D. Sit, Y. Lee, H. Gomaa, C. Valli, M.J. Swierz, Y. Chang, P. Alonso-Coello, M.M. Bala, B.C. Johnston.
Collection and assembly of data: R.W.M. Vernooij, D. Zeraatkar, M.A. Han, R. El Dib, M. Zworth, K. Milio, D. Sit, Y. Lee, H. Gomaa, M.J. Swierz, Y. Chang, B.C. Johnston.
This article was published at Annals.org on 1 October 2019.
* Dr. Vernooij and Ms. Zeraatkar contributed equally to this work.



Comments
0 Comments
Sign In to Submit A Comment